Headaches Seven studies were identified concerning headache, migraine, and idiopathic intracranial hypertension (IIH) [23,24,25,26,27,28,29]
1,13,14 Metformin, an insulin-sensitizing agent, is a second-line treatment option for metabolic concerns when oral contraceptives and lifestyle changes do not provide satisfactory results
Who is this not for
Key questions to discuss include: Whether you meet NHS criteria for GLP-1 prescription (type 2 diabetes or obesity with complications) The evidenceor lack thereoffor GLP-1 use specifically in Hashimoto's management Potential interactions between GLP-1 medications and thyroid hormone replacement How GLP-1 therapy might affect your thyroid function monitoring schedule Alternative evidence-based approaches to managing metabolic symptoms in Hashimoto's The costs and practicalities of private prescription if NHS funding is not available Contraception requirements if you are of childbearing potential (GLP-1 medications should be avoided in pregnancy and breastfeeding) Your GP may recommend optimising your current thyroid management first , ensuring your levothyroxine dose is appropriate and that you are not over- or under-replaced
Emerging evidence identifies AA/AdA-derived phosphatidylethanolamine (PE) as a pivotal substrate for ferroptotic lipid peroxidation (Kagan et al., 2017
Incretin Hormones Hormones released by the gut after eating that stimulate insulin production and reduce blood sugar